Although aberrant Ca 2+ release (i.e. Ca 2+ 'leak') from the sarcoplasmic reticulum (SR) through cardiac ryanodine receptors (RyR2) is linked to heart failure (HF), it remains unknown whether and under what conditions SR-derived Ca 2+ can actually cause HF. We tested the hypothesis that combining dysregulated RyR2 function with facilitated Ca 2+ uptake into SR will exacerbate abnormal SR Ca 2+ release and induce HF. We also examined the mechanisms for these alterations.
Introduction
Abnormal intracellular calcium (Ca 2+ ) handling, and in particular, dysregulated Ca 2+ release from the sarcoplasmic reticulum (SR), has been implicated in a range of cardiac diseases, including arrhythmias and systolic heart failure (HF). 1 in the SR and facilitating RyR2 closure during the diastolic phase. 2 Reuptake of Ca 2+ by the SR Ca 2+ ATPase (SERCA2a) pump initiates diastolic relaxation. Mutations in RyR2 and CASQ2 have been linked to catecholaminergic polymorphic ventricular tachycardia (CPVT), a cardiac rhythm disorder characterized by episodes of ventricular tachycardia following exercise or infusion of catecholamines in patients with otherwise functionally and anatomically normal hearts. 3 At myocyte level, the mutations have been shown to destabilize RyR2 activity thus causing premature Ca 2+ release in the form of spontaneous Ca 2+ waves, followed by oscillations of membrane potential, known
as delayed afterdepolarizations, and extra-systolic action potentials. 4, 5 However, the mechanisms underlying the adverse effects of adrenergic stimulation in CPVT remain to be fully elucidated. It has also been suggested that excessive diastolic SR Ca 2+ release causes HF, 6 -8 release, in turn leading to apoptotic myocyte death, dilated cardiomyopathy, and early mortality.
Methods
For details regarding methods, refer to the Supplementary material online, Methods.
Generation of mouse models
Double-mutant mice for CASQ2 and SERCA1a were generated by breeding two previously described mouse models, the SERCA1a TG mouse 13 with the CASQ2 KO mouse. 16 WT, TG, KO, CASQ2 heterozygous expressing SERCA1a (HETxTG), and KO expressing SERCA1a (KOxTG) mice were used for the study. Double knockout mice (DKO) for CASQ2 and PLB were created by breeding KO mice for CASQ2 16 with PLB.KO mice. 14 
Echocardiography and electrocardiographic recordings
Echocardiographic (ECG) examination was performed to assess systolic and diastolic function in lightly anaesthetized mice (1.5% isoflurane), using the Vevo 2100 echocardiograph system (with a 30 MHz probe), following standard techniques, as previously described. Continuous ECG recordings were obtained from mice anaesthetized with isoflurane, at minimum effective concentration (1 -1.5%) before and after catecholaminergic challenge [isoproterenol (ISO) (1.5 mg/kg ip)], as previously described. Anaesthesia of mice was considered sufficient when the paw pinch test was negative.
Western blotting
Quantitative immunoblotting was done as previously reported.
Evaluation of apoptosis using TUNEL staining
Paraformaldehyde-fixed whole heart sections were stained for TUNELpositive nuclei, using a kit (ROCHE) according to the manufacturer's instructions.
Cardiac muscle preparation
Mice were administered heparin [40 mL, heparin sodium 10 000 U/mL, APP Pharmaceuticals, LLC, Schaumburg, IL, USA (ip)] 10 min before receiving anaesthesia (pentobarbital sodium 70 mg/kg, ip, Lundbeck Inc., Deerfield, IL, USA). Anaesthesia of mice was considered sufficient when the paw pinch test was negative. Thin, uniform, non-branched trabeculae, or small papillary muscles from the right ventricle were mounted between a force transducer and a micromanipulator and stretched to an optimal length as previously described. All experiments were performed at 378C. The developed tension was recorded with the LabView software and normalized to the cross-sectional area of the muscle. Figure 1C ). 
CASQ2-deficient mice overexpressing SERCA1a display dilated cardiac hypertrophy and contractile dysfunction
We further examined the structural and functional alterations in the double-mutant hearts using histological and haemodynamic assays. Haematoxylin and Eosin staining revealed widespread signs of degenerative changes in HETxTG and KOxTG cardiomyocytes including loss of striations, vacuolation, megakaryosis, and mineralization ( Figure 1F ). Additionally, Masson trichrome staining exposed focal areas of moderate interstitial fibrosis in sections from double-mutant hearts ( Figure 1G ) compared with the normal histology from the agematched WT and KO cardiac sections. No significant differences in the cardiomyocyte size were observed in the TG (199 + 1 mm WT and KO hearts, respectively ( Figure 1D and H ). In both genotypes, myocyte hypertrophy was not regionally restricted but observed consistently both transmurally and from the apex to the base of the ventricles. Left ventricular (LV) enlargement and impaired cardiac function in mice combining CASQ2 ablation and SERCA1a expression were indicated by echocardiography (Figure 2A) . The end-diastolic diameter of the left ventricle was significantly enlarged (3.54 + 0.13 vs. 4.48 + 0.2 mm, P , 0.05) and LV posterior wall dimension diastole (LVPWD) was decreased (0.95 + 0.06 vs. 0.73 + 0.05 mm, P , 0.05) in the WT vs. the HETxTG mice (see Supplementary material online, Table S1 ). Ejection fraction was reduced in double-mutant mice ( Figure 2B ). Taken together, these results suggest that doublemutant mice developed dilated cardiomyopathy.
3.3 Catecholamine-induced arrhythmias are exacerbated in CASQ2-deficient mice overexpressing SERCA1a ECG traces were recorded from lightly anaesthetized mice before and after catecholaminergic challenge with ISO. Continuous ECG monitoring showed a nearly normal sinus rhythm at the baseline, except for a relatively few cases of premature ventricular complexes (PVCs) in the HETxTG group (see Supplementary material online, Figure S1A ). Following the ISO challenge, both the HETxTG and the KOxTG groups showed a marked increase in the incidence of arrhythmias (see Supplementary material online, Figure S1B ). Importantly, while the HETxTG mice primarily displayed simple ventricular arrhythmias (consisting of PVCs and fusion beats), the KOxTG mice also developed complex ventricular arrhythmias, including ventricular tachycardia (see Supplementary material online, Figure S1B -D). 
Intrinsic cardiac muscle contractility is preserved in CASQ2-deficient mice expressing SERCA1a
To determine whether the impaired LV haemodynamic performance in double-mutant mice is associated with weakening of intrinsic myocardial contractility, we performed contractile force measurements in ventricular papillary muscles paced at 4 Hz at 378C. As shown in Figure 3 , the systolic contractile force in the HETxTG muscles, rather than being weaker, tended to be stronger than in the agematched WT muscles. Similarly, the KOxTG muscles contracted more strongly than the KO muscles. Of note, both HETxTG and KOxTG muscles showed occasional spontaneous diastolic contractions, which were rarely observed in the WT, TG, and the KO muscles ( Figure 3A , bottom panels; Figure 3C ) repetitive multiple propagating wave-or wavelet-like signals in both KOxTG and HETxTG myocytes ( Figure 4A and F ) . All the other groups, including TG and KO myocytes, exhibited such spontaneous releases at much lower rates under the same experimental conditions ( Figure 4B ). In addition, average diastolic Ca 2+ , as a total measure of diastolic release, was significantly increased in the double-mutant myocytes compared with the other groups (see Supplementary material online, Figure S2 ). Of note, the amplitude of systolic Ca 2+ transients and SR Ca 2+ content in the double-mutant myocytes were either higher or similar to those in the WT but lower than those in the TG myocytes. The reduced SR Ca 2+ content of the doublemutant myocytes relative to the SERCA1a myocytes is evidently due to the increased diastolic release in the double-mutant myocytes which would be expected to deplete the SR Ca 2+ store ( Figure 4C-E) .
Ca 2+ currents measured in separate experiments in the doublemutant myocytes were not significantly different in amplitude compared with the WT and the other groups (see Supplementary material online, Figure S3 ). Additionally, key Ca 2+ -handling proteins, including SERCA1a, SERCA2a, CASQ2, RyR2, and PLB, were assessed by western blotting in the hearts from different groups (see Supplementary material online, Figure S4 ). SERCA1a levels were similar in all the groups overexpressing this protein. Consistent with previous results, endogenous SERCA2a 13 and RyR2 17 were decreased in the hearts overexpressing SERCA1a. The effects of ISO on Ca 2+ handling were investigated in the HETxTG myocytes ( Figure 4F and G) . At baseline, the myocytes exhibited occasional spontaneous releases of different sizes from small wavelets to full waves. All spontaneous release events were grouped into three categories according to their size (i.e. full waves and wavelets with width of either ≥ 10 mm or 5-10 mm) ( Figure 4G ). ISO caused a marked increase in the rate of occurrence of all types of events including full Ca 2+ waves.
Increased cardiomyocyte apoptosis in CASQ2-deficient mice overexpressing SERCA1a
Collectively, the data presented above indicate that weakening of in vivo mechanical performance of double-mutant hearts occurs without a corresponding weakening of systolic Ca 2+ release and contractile force in cardiac myocytes. This apparent discrepancy could be explained by increased myocyte loss leading to LV chamber dilation, a possibility also consistent with the significant LV dilation revealed by our histological analyses ( Figure 1E ). TUNEL staining of tissue sections from both the HETxTG and the KOxTG hearts displayed significant increases in the fraction of apoptotic nuclei [0.6 and 0.9%, respectively (P , 0.05)] compared with the WT and the KO groups (0.1%; P , 0.05) ( Figure 5A ). Additionally, expression of the pro-apoptotic form of Caspase 3 (17 kDa fragment) was significantly increased in the HETxTG (one fold; P , 0.05) and KOxTG (1.7 fold; P , 0.05) mice compared with the WT and the KO hearts, respectively. ( Figure 5B) . Thus, myocyte loss could indeed contribute to the in vivo cardiac contractile dysfunction in double-mutant mice by reduced myocyte number and increased LV diameter, thereby reducing LV pressure (see 'Section 4'). (Figure 6 ), and increased Caspase 3 fragments ( Figure 5B ). Although the results were qualitatively similar, the DKO mice lived relatively longer than the HETxTG and the KOxTG mice, indicating that the number of active pumps could play a significant role in modulating the magnitude of RyR2 leak and hence its deleterious effects.
Discussion
In the present study, we investigated the consequences of combining dysregulated RyR2 function with facilitated SR Ca 2+ uptake by crossing genetically altered mice deficient in expression of CASQ2 with mice overexpressing SERCA1a (or ablation of PLB, a negative regulator of SERCA2a). Myocytes from the crossbred mice displayed increased diastolic Ca 2+ release with preserved myocyte systolic Ca 2+ release and contractility. Strikingly, the hybrid mice died prematurely and developed cardiac failure characterized by enhanced myocyte apoptotic death, hypertrophic chamber dilation, and haemodynamic deficiency. These findings present important implications for the pathophysiology and treatment of HF. Figures 3 and 4) .
Furthermore, our data demonstrate that under conditions of sustained RyR2-mediated diastolic release, HF can develop without signs of myocyte contractile failure as a result of myocyte loss and dilation of the LV chamber. Indeed according to the Laplace's law, ventricular pressure will fall with increasing chamber diameter and wall thickness even if wall tension due to myocyte contraction is preserved. Notably, the 50% increase in end-diastolic LV diameter and the 20% decrease in LV wall thickness observed in the HETxTG mice at a constant wall tension translate into nearly two-fold decrease in systolic LV pressure consistent with the 2.5-fold decrease in ejection fraction in these mice ( Figure 2) . It is well established that mitochondrial Ca 2+ overload results in mitochondrial injury associated with myocyte apoptosis or necrosis. 28 -30 In addition, several major signalling pathways have been implicated in the activation of the cardiac hypertrophic response following elevations of intracellular Ca 2+ , including the calcineurin/NFAT and the CaMKII/HDAC pathways. 31 -33 Despite their important role in the development of cardiac pathological remodelling, the exact subcellular sources of Ca 2+ involved in mitochondria-mediated cell death and Ca 2+ -dependent hypertrophy remain poorly defined.
Our results clearly point to a role for SR-derived Ca 2+ in these pathological processes.
Increased SR Ca 21 uptake and arrhythmogenesis in CPVT
In CPVT, episodes of arrhythmia are provoked by exercise or emotional stress associated with increased levels of circulating catecholamines in both patients and genetic mouse models of this syndrome. 3 Although the catecholamine-dependency of CPVT is likely to have complex causes, it has been suggested that stimulation of SERCA2a (via phosphorylation of PLB) is a potential mechanism for the pro-arrhythmic effects of catecholamines. 4, 34 Facilitated SERCAmediated SR Ca 2+ uptake is expected to increase myocyte arrhythmic potential by maintaining the SR Ca 2+ content at levels conducive to spontaneous Ca 2+ release generation. Consistent with this expectation, CASQ2-deficient myocytes overexpressing SERCA1a exhibited a higher propensity for spontaneous SR Ca 2+ release than either the WT or the KO myocytes in the absence of b-adrenergic stimulation ( Figure 4) . Surprisingly, increased spontaneous SR Ca 2+ release propensity did not translate into higher arrhythmia vulnerability in double-mutant mice under baseline conditions (no ISO). However, the severity of arrhythmias provoked by ISO was markedly exacerbated in the double-mutant mice compared with the KO mice (see Supplementary material online, Figure S1 ). Other factors such as functional heterogeneities in the heart during catecholamine stimulation 35 (as opposed to homogeneous functional changes resulting from cardiac expression of SERCA1a) seem to be required to provide a necessary substrate for arrhythmias. Further studies will have to look into this important issue.
SERCA up-regulation as therapy for HF
Up-regulation of SR Ca 2+ re-uptake through expression of SERCA2a or ablation of PLB are promising gene therapy approaches based on their beneficial effects in a number of animal models of HF. 36, 37 Despite many successful examples, this approach has failed to reverse HF or has even exacerbated cardiac dysfunction in some studies. 38 -40 Our results demonstrate that up-regulation of SERCAmediated SR Ca 2+ uptake either by directly increasing the number of SERCA pumps or by disinhibition of endogenous SERCA pumps via ablation of PLB, when combined with dysregulated RyR2s, can be severely detrimental rather than therapeutic. RyR2s are known to become hyperactive or 'leaky' in certain HF settings as a result of post-translational modifications through phosphorylation and/or oxidation. 6, 21, 41 Our data suggest that SERCA therapy should be advocated with caution in failing hearts given the possibility of pathological interaction of facilitated SR Ca 2+ uptake with dysregulated RyR2 function.
Potential limitations
A potential limitation of this study is that SERCA1a, normally absent in cardiac myocytes, might be considered 'non-physiological' and therefore detrimental to cardiac function. However, as shown previously, SERCA1a can functionally substitute SERCA2a in the cardiac muscle without detrimental changes in phenotype. 13 Additionally, when we used ablation of PLB to facilitate SR Ca 2+ uptake against the background of CASQ2.KO, we obtained results similar to those attained in our original double-mutant strains. It is also to be noted that as in all studies involving manipulation of individual genes, changes in SERCA1a and CASQ2 are likely to be associated with alterations in expression/activity of other proteins; thus, we cannot rule out the possibility of such compensatory changes influencing our results.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
